Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma.

Barbieri RB, Bufalo NE, Secolin R, Assumpção LV, Maciel RM, Cerutti JM, Ward LS.

Eur J Endocrinol. 2014 Dec;171(6):761-7. doi: 10.1530/EJE-14-0461.

PMID:
25565272
2.

Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma.

Barbieri RB, Bufalo NE, Secolin R, Silva AC, Assumpção LV, Maciel RM, Cerutti JM, Ward LS.

Eur J Endocrinol. 2012 Feb;166(2):241-5. doi: 10.1530/EJE-11-0843. Epub 2011 Nov 2.

PMID:
22048975
3.

Additive effect of RET polymorphisms on sporadic medullary thyroid carcinoma susceptibility and tumor aggressiveness.

Ceolin L, Siqueira DR, Ferreira CV, Romitti M, Maia SC, Leiria L, Crispim D, Ashton-Prolla P, Maia AL.

Eur J Endocrinol. 2012 May;166(5):847-54. doi: 10.1530/EJE-11-1060. Epub 2012 Feb 17. Erratum in: Eur J Endocrinol. 2012 Jun;166(6):1121. Prolla, Patrícia Ashton [corrected to Ashton-Prolla, Patrícia].

PMID:
22345297
4.

Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer.

Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, Green AC, Whiteman DC; Australian Ovarian Cancer Study Group, Goodman MT, Lurie G, Carney ME, Modugno F, Ness RB, Edwards RP, Moysich KB, Goode EL, Couch FJ, Cunningham JM, Sellers TA, Wu AH, Pike MC, Iversen ES, Marks JR, Garcia-Closas M, Brinton L, Lissowska J, Peplonska B, Easton DF, Jacobs I, Ponder BA, Schildkraut J, Pearce CL, Chenevix-Trench G, Berchuck A, Pharoah PD; Ovarian Cancer Association Consortium.

Cancer Res. 2007 Apr 1;67(7):3027-35.

5.

CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.

Kibel AS, Suarez BK, Belani J, Oh J, Webster R, Brophy-Ebbers M, Guo C, Catalona WJ, Picus J, Goodfellow PJ.

Cancer Res. 2003 May 1;63(9):2033-6.

6.

The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.

Siqueira DR, Romitti M, da Rocha AP, Ceolin L, Meotti C, Estivalet A, Puñales MK, Maia AL.

Endocr Relat Cancer. 2010 Oct 5;17(4):953-63. doi: 10.1677/ERC-09-0312. Print 2010 Dec.

PMID:
20801952
7.

CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.

Pasquali D, Circelli L, Faggiano A, Pancione M, Renzullo A, Elisei R, Romei C, Accardo G, Coppola VR, De Palma M, Ferolla P, Grimaldi F, Colao A, Colantuoni V.

Eur J Endocrinol. 2011 Mar;164(3):397-404. doi: 10.1530/EJE-10-0929. Epub 2010 Dec 21.

PMID:
21177330
8.

Role of CDKN2C Fluorescence In Situ Hybridization in the Management of Medullary Thyroid Carcinoma.

El Naofal M, Kim A, Yon HY, Baity M, Ming Z, Bui-Griffith J, Tang Z, Robinson M, Grubbs EG, Cote GJ, Hu P.

Ann Clin Lab Sci. 2017 Sep;47(5):523-528.

PMID:
29066476
9.

[RET and GFRA1 germline polymorphisms in medullary thyroid cancer patients].

Severskaia NV, Saenko VA, Il'in AA, Chebotareva IV, Rumiantsev PO, Isaev PA, Medvedev VS, Iasmita S.

Mol Biol (Mosk). 2006 May-Jun;40(3):425-35. Russian.

PMID:
16813162
10.

Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.

Ruiz A, Antiñolo G, Fernández RM, Eng C, Marcos I, Borrego S.

Clin Endocrinol (Oxf). 2001 Sep;55(3):399-402.

PMID:
11589684
11.

Analysis of somatic mutations in BRAF, CDKN2A/p16 and PI3KCA in patients with medullary thyroid carcinoma.

Nascimento FP, Cardoso MG, Lindsey SC, Kunii IS, Valente FO, Kizys MM, Delcelo R, Camacho CP, Maciel RM, Dias-Da-Silva MR.

Mol Med Rep. 2016 Feb;13(2):1653-60. doi: 10.3892/mmr.2015.4731. Epub 2015 Dec 29.

PMID:
26718898
12.

Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.

Akulevich NM, Saenko VA, Rogounovitch TI, Drozd VM, Lushnikov EF, Ivanov VK, Mitsutake N, Kominami R, Yamashita S.

Endocr Relat Cancer. 2009 Jun;16(2):491-503. doi: 10.1677/ERC-08-0336. Epub 2009 Mar 13.

PMID:
19286843
13.

Genome-wide copy number analysis in a family with p.G533C RET mutation and medullary thyroid carcinoma identified regions potentially associated with a higher predisposition to lymph node metastasis.

Araujo AN, Moraes L, França MI, Hakonarson H, Li J, Pellegrino R, Maciel RM, Cerutti JM.

J Clin Endocrinol Metab. 2014 Jun;99(6):E1104-12. doi: 10.1210/jc.2013-2993. Epub 2014 Mar 6.

PMID:
24601688
14.

Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.

Polakova V, Pardini B, Naccarati A, Landi S, Slyskova J, Novotny J, Vodickova L, Bermejo JL, Hanova M, Smerhovsky Z, Tulupova E, Kumar R, Hemminki K, Vodicka P.

Hum Mutat. 2009 Apr;30(4):661-8. doi: 10.1002/humu.20931.

PMID:
19224585
15.
16.

Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.

Machens A, Dralle H.

Eur J Surg Oncol. 2015 Jun;41(6):766-72. doi: 10.1016/j.ejso.2014.10.049. Epub 2014 Oct 27.

PMID:
25468749
17.

Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.

Driver KE, Song H, Lesueur F, Ahmed S, Barbosa-Morais NL, Tyrer JP, Ponder BA, Easton DF, Pharoah PD, Dunning AM; Studies in Epidemiology and Risks of Cancer Heredity (SEARCH) Team.

Carcinogenesis. 2008 Feb;29(2):333-41. doi: 10.1093/carcin/bgm284. Epub 2008 Jan 3.

18.

Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways.

Ameur N, Lacroix L, Roucan S, Roux V, Broutin S, Talbot M, Dupuy C, Caillou B, Schlumberger M, Bidart JM.

Endocr Relat Cancer. 2009 Dec;16(4):1261-72. doi: 10.1677/ERC-08-0289. Epub 2009 Aug 12.

PMID:
19675075
19.

Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.

Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Phelan CM, Anderson S, Rider DN, White KL, Pankratz VS, Song H, Hogdall E, Kjaer SK, Whittemore AS, DiCioccio R, Ramus SJ, Gayther SA, Schildkraut JM, Pharaoh PP, Sellers TA.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):935-44. doi: 10.1158/1055-9965.EPI-08-0860. Epub 2009 Mar 3.

20.

The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.

Weinhaeusel A, Scheuba C, Lauss M, Kriegner A, Kaserer K, Vierlinger K, Haas OA, Niederle B.

Thyroid. 2008 Dec;18(12):1269-76. doi: 10.1089/thy.2008.0139.

PMID:
18976163

Supplemental Content

Support Center